These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29225856)

  • 81. Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
    Kuye O; Teal J; DeVries VG; Morrow CA; Tally FP
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():113-24. PubMed ID: 8383652
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.
    Mouton Y; Leroy O; Beuscart C; Chidiac C; Senneville E; Ajana F; Lecocq P
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():87-95. PubMed ID: 8383658
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
    Siami FS; LaFleur BJ; Siami GA
    Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Vickery SB; McClain D; Wargo KA
    Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
    Carreno J; Smiraglia T; Hunter C; Tobin E; Lomaestro B
    Int J Antimicrob Agents; 2018 Nov; 52(5):643-650. PubMed ID: 30103003
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae.
    Akhan S; Coskunkan F; Tansel O; Vahaboglu H
    Scand J Infect Dis; 2001; 33(7):512-5. PubMed ID: 11515761
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
    Verhoven SM; Groszek JJ; Fissell WH; Seegmiller A; Colby J; Patel P; Verstraete A; Shotwell M
    Clin Chim Acta; 2018 Jul; 482():60-64. PubMed ID: 29596815
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor.
    Haley KM; Russell TB; Boshkov L; Leger RM; Garratty G; Recht M; Nazemi KJ
    J Blood Med; 2014; 5():55-8. PubMed ID: 24868179
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Drug-Induced Hypersensitivity Syndrome With Hemophagocytic Lymphohistiocytosis Related to Piperacillin-Tazobactam: A Case Report.
    Shen Y; Teng X; Zha L; Han M; Wang Q
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):493-495. PubMed ID: 36988092
    [No Abstract]   [Full Text] [Related]  

  • 90. Piperacillin/tazobactem induced epistaxis- A case report.
    Tomar GS; Agrawal RS; Kalyankar VB; Chawla S; Tiwari AK
    J Anaesthesiol Clin Pharmacol; 2012 Jul; 28(3):404-5. PubMed ID: 22869960
    [No Abstract]   [Full Text] [Related]  

  • 91. [In macrohematuria, medication history also needs to be considered : Penicillin-induced immune hemolysis: a case report and review of literature].
    Schlatterer K; Marschner M; Hausdorf C
    Inn Med (Heidelb); 2023 Dec; 64(12):1218-1223. PubMed ID: 37493757
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The First-Reported Case of Drug-Induced Hemolytic Anemia by Piperacillin-Tazobactam in a Premature Neonate: A Case Report and Literature Review.
    Salim H; Musmar B; A Sarhan FM; Giacaman N; Abu Omar S
    Cureus; 2023 Mar; 15(3):e35915. PubMed ID: 37038577
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
    Roehmel J; Specht P; Staab D; Schwarz C; Salama A; Mayer B
    Transfusion; 2019 Dec; 59(12):3746-3754. PubMed ID: 31724753
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
    Meinus C; Schwarz C; Mayer B; Roehmel JF
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797815
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient.
    Kerkhoff AD; Patrick L; Cornett P; Kleinhenz ME; Brondfield S
    Clin Case Rep; 2017 Dec; 5(12):2059-2061. PubMed ID: 29225856
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
    Bandara M; Seder DB; Garratty G; Leger RM; Zuckerman JB
    Case Rep Med; 2010; 2010():161454. PubMed ID: 20589083
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
    Wu Y; Wu Y; Guo G; Zeng J; Liu Y; Wu Y
    BMC Nephrol; 2023 Jun; 24(1):173. PubMed ID: 37316798
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.